MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial

For rare cancers, challenges in establishing standard therapies are greater than those for major cancers, and effective methods are needed. MASTER KEY Project is a multicenter study based in Japan, with two main parts: prospective registry study and multiple clinical trials. Advanced rare cancers, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuma, Hitomi S., Yonemori, Kan, Narita, Shoko N., Sukigara, Tamie, Hirakawa, Akihiro, Shimizu, Toshio, Shibata, Taro, Kawai, Akira, Yamamoto, Noboru, Nakamura, Kenichi, Nishida, Toshiro, Fujiwara, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484913/
https://www.ncbi.nlm.nih.gov/pubmed/32112563
http://dx.doi.org/10.1002/cpt.1817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484913/
https://www.ncbi.nlm.nih.gov/pubmed/32112563
http://dx.doi.org/10.1002/cpt.1817

Ejemplares similares